Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cytokeratin 18 a Novel Non-invasive Biomarker for Rejection in Liver Transplant Patients

NCT06153641 is registered in ClinicalTrials.gov with St. Louis University as lead sponsor.

NCT NCT06153641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06153641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cytokeratin 18 a Novel Non-invasive Biomarker for Rejection in Liver Transplant Patients
Lead sponsor
St. Louis University
Phase
Observational
Overall status
Active, not recruiting
Start date
April 16, 2019
Completion date
March 31, 2026
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant failure and rejection, liver transplant rejection